CLINICAL_TRIALS
research
· 2016-02-02
Clinical Trial Update: Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients [Phase 4]
Summary
A Phase 4 clinical trial exploring pharmacology-driven dosing of fluoropyrimidines in colorectal cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cantonal Hospital of St. Gallen | Conditions: Colorectal Cancer | Phase 4 | Status: COMPLETED